A scientist walks into a bar, sits down with a former producer of 60 Minutes, Steven Reiner, orders a beer and talks to a live audience. No punch line here! This is Science on Tap, a live, award-winning show and web series produced by Graham Chedd, a Visiting Professor at the Alda Center and producer of the PBS series Scientific American Frontiers.
Watch All Science On Tap
Watch the Latest Episode
During this live recording of Science On Tap, Yusuf Hannun, MD, Director of the Stony Brook University Cancer Center will explain how a recent multi-million-dollar gift to the Center will open new pathways to the diagnosis and treatment of cancer. Dr. Hannun will also share the plans to expand The Kavita and Lalit Bahl Center for Metabolomics and Imaging at Stony Brook University, a one-of-a-kind cancer research program with a new facility opening on the Stony Brook Medicine campus in 2018.
A scientist walks into a bar, sits down with a former producer of 60 Minutes, Steven Reiner, orders a beer and talks to a live audience. No punch line here! This is Science on Tap, a live, award-winning show and web series produced by Graham Chedd, a Visiting Professor at the Alda Center and producer of the PBS series Scientific American Frontiers.
Watch All Science on Tap
Be Our Guest
If you’d like to be featured on a future episode of Science On Tap, please complete our application form.
If you have a question or idea, please contact us.
Watch the Latest Episode
Biomedical scientists like Chris Vakoc have recently gained an unprecedented ability to edit life’s instruction manual – DNA – with a new tool whose ungainly name – CRISPR-cas9 – is (thankfully) usually shortened to “crisper.” Chris will share with host Graham Chedd and our audience how the technology was discovered, how it works and some of the astonishing things it can do. He’ll include examples from his own lab at Cold Spring Harbor Laboratory, where his team has developed a new method for discovering promising anti-cancer drugs. Graham and Chris will also dive into the thorny question of whether CRISPR will one day soon be used to edit the genes of people.